Evidence map›Paper›PMID 42309337›Full record

ArticleMolecular & cellular proteomics : MCP2026

Optimizing NGN2 Dosage Enhances the Neuronal Enrichment of iPSC-Derived Neuronal Cultures.

Jesús Muñoz-Estrada, Andrew Mostafania, Lahiruni Halwatura, Ali Haghani, Yuming Jiang, Jesse G Meyer

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jesús Muñoz-EstradaDepartment of Computational Biomedicine, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, California, USA. Electronic address: JosedeJesus.MunozEstrada@cshs.org.
Andrew MostafaniaDepartment of Computational Biomedicine, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, California, USA.
Lahiruni HalwaturaDepartment of Computational Biomedicine, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, California, USA.
Ali HaghaniDepartment of Computational Biomedicine, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, California, USA.
Yuming JiangDepartment of Computational Biomedicine, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, California, USA.
Jesse G MeyerDepartment of Computational Biomedicine, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, California, USA. Electronic address: Jesse.Meyer@cshs.org.

Funding

Democratizing Multi-Omics to Expedite Discovery of Hidden Metabolic PathwaysR35GM142502 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI MEYER, JESSE · 2021 to 2025
$2.2M
Drug Discovery for Alzheimer’s Disease Enabled by Multi-Omics and Artificial IntelligenceR21AG074234 · NIA · MEDICAL COLLEGE OF WISCONSIN · PI MEYER, JESSE · 2021 to 2022
$443k
NIA NIH HHS R21 AG074234NIGMS NIH HHS R35 GM142502
6 · The paper itself

Abstract

Proteomic analysis of highly neuron-enriched iPSC-derived cultures can provide valuable insights into the pathogenesis of neurological disease by minimizing confounding signals from non-neuronal populations. However, single-cell iPSC clones with stable NGN2 integration at the AAVS1 locus exhibit spontaneous loss of the mCherry reporter. In addition, following NGN2 induction, cultures frequently contain proliferative progenitor cells that compromise neuronal physical integrity. Here, we show that increased DNA methylation of the EF1-α promoter is associated with mCherry silencing. Importantly, reporter silencing does not affect iNeuron derivation, as evidenced by two lines of evidence. First, single-cell proteomic analysis indicated that mCherry silencing does not drive detectable proteomic divergence in undifferentiated iPSCs. Second, bulk proteomics and immunofluorescence analyses indicated that iPSC-derived neuronal cultures, whether expressing or lacking mCherry, resemble cortical glutamatergic neurons. Instead, the primary confounding factor in iNeuron generation was suboptimal neuronal conversion, which led to cell aggregates comprised of actively proliferating progenitor cells and astrocytes as the culture developed. We found that a 4-day period of NGN2 induction substantially increases neuronal maturation and the expression of neuronal-specific markers. Moreover, transient inhibition of Notch signaling is consistent with a reduction in progenitor cells. Finally, we observed that monoallelic NGN2 integration, rather than biallelic integration, preferentially increases expression of the CNS neuronal marker GPM6A over PNS markers (PRPH, POU4F1, ILS1).

Indexed as

Basic Helix-Loop-Helix ProteinsGene DosageInduced Pluripotent Stem CellsNerve Tissue ProteinsNeuronsAnimalsCell DifferentiationCells, CulturedDNA MethylationHumansPromoter Regions, GeneticProteomicsReceptors, NotchBasic Helix-Loop-Helix ProteinsNerve Tissue ProteinsNEUROG2 protein, humanReceptors, NotchAAVS1bulk proteomicsEF1α transgene silencinginduced pluripotent stem cells (iPSCs)iPSC-derived neuronal-enriched culturesKOLF2.1JNeurogenin-2 (NGN2) stable integration;NGN2 dosageNotch signalingsingle-cell proteomics

Identifiers

PMID42309337
PMCPMC13382583

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.